Developer docs
API playgroundTry for free, no card

Search company profiles

NuvemRx

Full company profile

uuid0005c6z

Namestring
NuvemRx
Legal namestring
340B Technologies, Inc.
Websiteurl
nuvemrx.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSharon Hill, United States
HQ citystring
Sharon Hill
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
340B pharmacy management, third-party administration, contract pharmacy services, specialty referral management, community health pharmacy
Industry3 codes
PRIMARYHLACAKAC
Pharmacy Information Systems (PIS) & Dispensing Workflow
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAH
Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Hospital & Medical Service Plans6324
Product category
340B Pharmacy Management Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Third-Party Administration (TPA) Services
TypeManaged Services
Description

NuvemRx operates as a Third-Party Administrator (TPA) for 340B programs, providing contract pharmacy management services to covered entities. Revenue is generated through service fees charged to community health centers for managing their 340B pharmacy programs, including claims processing, compliance monitoring, and reporting.

2Entity-Owned Pharmacy Management
TypeManaged Services
Description

NuvemRx provides comprehensive pharmacy management solutions for health centers operating their own in-house pharmacies. Services include pharmacy setup, staffing, operations management, and ongoing optimization, generating recurring service fees.

3Specialty Care Referral Services
TypeSubscription Recurring
Description

Following the par8o acquisition, NuvemRx offers specialty referral management services including referral capture, authorization automation, and network optimization. These services help reduce referral leakage and expand patient access while generating service-based revenue.

4Program Integrity and Compliance Services
TypeProfessional Services
Description

Compliance-focused services including quarterly 340B audits, federal audit preparation, and regulatory guidance. These advisory services are bundled with core offerings or provided as standalone consulting engagements.

nuvemrx.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise pricing for covered entities
ModelOtherBilling cadenceAnnual
Notes

Pricing model drives aligned incentives with customers and transparency across TPAs. No specific tiers, price points, or per-transaction fees disclosed.

nuvemrx.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1NuTPA
Description

Contract Pharmacy solution providing simplified TPA services, pricing transparency, automated workflows, and expert support for 340B contract pharmacy management.

nuvemrx.com
+4 more records
Core offering1 text field

NuvemRx provides 340B pharmacy management services to community health providers through three core offerings: NuTPA (Third-Party Administrator for contract pharmacies), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by par8o). These are delivered on the cloud-based Apollo Platform with AI-powered analytics and supported by the Mission Control expert team, helping covered entities manage compliance, capture savings, and operate pharmacy programs efficiently.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 800+ covered entities served nationwide with over 70 million cumulative patients
+5 more records
Product overview1 text field

NuvemRx offers a unified suite of pharmacy solutions for community health providers built on the Apollo Platform. The core offerings include NuTPA (contract pharmacy third-party administration), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by acquired par8o technology). These products integrate software, intelligence, and expert support through Mission Control to help covered entities manage 340B programs, optimize pharmacy operations, reduce referral leakage, and maintain compliance. The company formed in 2024 from the merger of 340Basics, Apovia, and Louvir, and expanded in 2026 through the acquisition of par8o's 340B referral capture business.

Product and service6 records
1NuTPA
CategoryContract Pharmacy / Third-Party Administration
2NuPharmacy
CategoryEntity-Owned Pharmacy Optimization
3NuReferrals
CategorySpecialty Care Referral Management
4Apollo Platform
CategoryTechnology Platform
5Mission Control
CategoryPharmacy Expert Advisory Services
6Program Integrity Service
Category340B Compliance Services
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-02
Description

NuvemRx acquired the 340B referral capture business par8o from R1 RCM in February 2026. This acquisition adds AI-powered referral technology and real-time referral visibility to NuvemRx's suite of services. par8o's COO joined NuvemRx's leadership team following the deal. par8o had been acquired by R1 RCM as part of the Cloudmed transaction in 2022.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-11
Description

Expanded partnership with 26Health to open their first entity-owned pharmacy in Orlando, Florida. The new pharmacy aims to improve access, compliance, and efficiency for the community health organization, with savings reinvested into additional community health programs.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

340B compliance and contract pharmacy software platform, acquired by McKesson. Competes with NuvemRx on automated split-billing, audit support, and 340B program integrity services for health centers and hospitals.

TypeBroad incumbent
Description

Healthcare revenue cycle management company that previously owned par8o (the 340B referral capture business NuvemRx acquired in Feb 2026). R1 still services 340B-adjacent workflows for health systems, partially overlapping with NuvemRx's NuReferrals offering.

TypeOthers
Description

HRSA-contracted prime vendor for the federal 340B Drug Pricing Program. An ecosystem enabler rather than direct competitor — Apexus administers the program's infrastructure that NuvemRx's clients and TPAs rely upon.

TypeOthers
Description

Pharmacy e-prescribing and health information network whose former legal head now serves as NuvemRx's CLO. Adjacent infrastructure provider whose e-prescribing backbone supports the prescription flow that 340B TPAs like NuvemRx process and optimize.

5RxBenefits
TypeBroad incumbent
Description

PBM advisory and TPA firm for self-funded employer plans; competes with NuvemRx on third-party administration, claims processing, and pharmacy benefit optimization across a different but related customer segment (employers and payers vs. FQHC covered entities).

TypeBroad incumbent
Description

Public pharmacy automation and medication management company whose former leaders now lead NuvemRx (CEO Scott Seidelmann, several VPs). Overlaps with NuvemRx in 340B TPA platform, pharmacy operations software, and adherence tools, but operates across a much broader pharmacy portfolio beyond 340B.

TypeBroad incumbent
Description

Tech-enabled patient access and pharmacy services company where NuvemRx's Chief Legal Officer previously served. Comparable in adjacent pharmacy services, manufacturer hub services, and patient affordability programs serving similar healthcare stakeholders.

8CoverMyMeds (McKesson)
TypeBroad incumbent
Description

Electronic prior authorization, e-prescribing, and medication access network within McKesson. Comparable in automating the prescription access workflow that NuvemRx also touches through smart script capture and AI-powered referral tools.

TypeDirect peer
Description

340B software and TPA platform providing split-billing, contract pharmacy management, and analytics to covered entities. Direct competitor for NuTPA and Apollo Platform capabilities in the same community health customer base.

TypeDirect peer
Description

Direct 340B third-party administrator for contract pharmacy programs serving FQHCs and safety-net providers. Competes head-to-head with NuvemRx's NuTPA offering on claims processing, split billing, and compliance services for similar covered-entity customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NuvemRx

340B Pharmacy Management Servicesnuvemrx.com

NuvemRx firmographics

Firmographics
Name
NuvemRx
Legal name
340B Technologies, Inc.
Website
https://nuvemrx.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

NuvemRx industry classification

Industry
Product category
340B Pharmacy Management Services
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Hospital & Medical Service Plans (6324)
akta.pro industry
PRIMARYHLACAKAC
Pharmacy Information Systems (PIS) & Dispensing Workflow
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLACAKAH
Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • 340B pharmacy management
  • Third-party administration
  • Contract pharmacy services
  • Specialty referral management
  • Community health pharmacy

Where NuvemRx is headquartered

Location

Headquarters

HQ city
Sharon Hill
HQ country
United States
HQ region
North America

Offices2 records

Markets served

NuvemRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Third-Party Administration (TPA) Services: NuvemRx operates as a Third-Party Administrator (TPA) for 340B programs, providing contract pharmacy management services to covered entities. Revenue is generated through service fees charged to community health centers for managing their 340B pharmacy programs, including claims processing, compliance monitoring, and reporting.
  2. Entity-Owned Pharmacy Management: NuvemRx provides comprehensive pharmacy management solutions for health centers operating their own in-house pharmacies. Services include pharmacy setup, staffing, operations management, and ongoing optimization, generating recurring service fees.
  3. Specialty Care Referral Services: Following the par8o acquisition, NuvemRx offers specialty referral management services including referral capture, authorization automation, and network optimization. These services help reduce referral leakage and expand patient access while generating service-based revenue.
  4. Program Integrity and Compliance Services: Compliance-focused services including quarterly 340B audits, federal audit preparation, and regulatory guidance. These advisory services are bundled with core offerings or provided as standalone consulting engagements.

Pricing tiers

ModelBillingPrice
OtherAnnualEnterprise pricing for covered entities

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

NuvemRx product offering

Product offering

Core offering

NuvemRx provides 340B pharmacy management services to community health providers through three core offerings: NuTPA (Third-Party Administrator for contract pharmacies), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by par8o). These are delivered on the cloud-based Apollo Platform with AI-powered analytics and supported by the Mission Control expert team, helping covered entities manage compliance, capture savings, and operate pharmacy programs efficiently.

Product overview

NuvemRx offers a unified suite of pharmacy solutions for community health providers built on the Apollo Platform. The core offerings include NuTPA (contract pharmacy third-party administration), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by acquired par8o technology). These products integrate software, intelligence, and expert support through Mission Control to help covered entities manage 340B programs, optimize pharmacy operations, reduce referral leakage, and maintain compliance. The company formed in 2024 from the merger of 340Basics, Apovia, and Louvir, and expanded in 2026 through the acquisition of par8o's 340B referral capture business.

Differentiator

Problem solved

Functional benefit

Brands

  • NuTPA: Contract Pharmacy solution providing simplified TPA services, pricing transparency, automated workflows, and expert support for 340B contract pharmacy management.
  • NuPharmacy
  • NuReferrals
  • Mission Control
  • Apollo Platform

Products and services

  • NuTPA
  • NuPharmacy
  • NuReferrals
  • Apollo Platform
  • Mission Control
  • Program Integrity Service

Quantifiable outcome

  • 800+ covered entities served nationwide with over 70 million cumulative patients
  • +5 more outcomes

Companies that use NuvemRx

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles4 records

NuvemRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature8 records

NuvemRx partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered major and core.

  • R1 RCMmajorStrategic or Co-development Partner · 2 February 2026NuvemRx acquired the 340B referral capture business par8o from R1 RCM in February 2026. This acquisition adds AI-powered referral technology and real-time referral visibility to NuvemRx's suite of services. par8o's COO joined NuvemRx's leadership team following the deal. par8o had been acquired by R1 RCM as part of the Cloudmed transaction in 2022.
  • 26HealthcoreStrategic or Co-development Partner · 11 December 2025Expanded partnership with 26Health to open their first entity-owned pharmacy in Orlando, Florida. The new pharmacy aims to improve access, compliance, and efficiency for the community health organization, with savings reinvested into additional community health programs.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

NuvemRx competitors and assessment

Company assessment

Direct peers

  • Verity Solutions (McKesson): 340B compliance and contract pharmacy software platform, acquired by McKesson. Competes with NuvemRx on automated split-billing, audit support, and 340B program integrity services for health centers and hospitals.
  • SunRx: 340B software and TPA platform providing split-billing, contract pharmacy management, and analytics to covered entities. Direct competitor for NuTPA and Apollo Platform capabilities in the same community health customer base.
  • CaptureRx: Direct 340B third-party administrator for contract pharmacy programs serving FQHCs and safety-net providers. Competes head-to-head with NuvemRx's NuTPA offering on claims processing, split billing, and compliance services for similar covered-entity customers.

Broad incumbents

  • R1 RCM: Healthcare revenue cycle management company that previously owned par8o (the 340B referral capture business NuvemRx acquired in Feb 2026). R1 still services 340B-adjacent workflows for health systems, partially overlapping with NuvemRx's NuReferrals offering.
  • RxBenefits: PBM advisory and TPA firm for self-funded employer plans; competes with NuvemRx on third-party administration, claims processing, and pharmacy benefit optimization across a different but related customer segment (employers and payers vs. FQHC covered entities).
  • Omnicell: Public pharmacy automation and medication management company whose former leaders now lead NuvemRx (CEO Scott Seidelmann, several VPs). Overlaps with NuvemRx in 340B TPA platform, pharmacy operations software, and adherence tools, but operates across a much broader pharmacy portfolio beyond 340B.
  • ConnectiveRx: Tech-enabled patient access and pharmacy services company where NuvemRx's Chief Legal Officer previously served. Comparable in adjacent pharmacy services, manufacturer hub services, and patient affordability programs serving similar healthcare stakeholders.
  • CoverMyMeds (McKesson): Electronic prior authorization, e-prescribing, and medication access network within McKesson. Comparable in automating the prescription access workflow that NuvemRx also touches through smart script capture and AI-powered referral tools.

Others

  • Apexus: HRSA-contracted prime vendor for the federal 340B Drug Pricing Program. An ecosystem enabler rather than direct competitor — Apexus administers the program's infrastructure that NuvemRx's clients and TPAs rely upon.
  • Surescripts: Pharmacy e-prescribing and health information network whose former legal head now serves as NuvemRx's CLO. Adjacent infrastructure provider whose e-prescribing backbone supports the prescription flow that 340B TPAs like NuvemRx process and optimize.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

NuvemRx social profiles

Digital presence

NuvemRx compliance and trust

Trust signal

Compliance1 record

NuvemRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NuvemRx leadership team

Management profile

Number of profiles

Profiles14 records

NuvemRx subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

NuvemRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NuvemRx M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NuvemRx

What does NuvemRx do?

NuvemRx provides 340B pharmacy management services to community health providers through three core offerings: NuTPA (Third-Party Administrator for contract pharmacies), NuPharmacy (entity-owned pharmacy optimization), and NuReferrals (specialty care referral capture powered by par8o). These are delivered on the cloud-based Apollo Platform with AI-powered analytics and supported by the Mission Control expert team, helping covered entities manage compliance, capture savings, and operate pharmacy programs efficiently.

Is NuvemRx a public or private company?

NuvemRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NuvemRx founded?

NuvemRx was founded in 2014. It employs 251 to 500 people.

Where is NuvemRx based?

NuvemRx is headquartered in Sharon Hill, United States, in the North America region.

How does NuvemRx make money?

Four revenue lines are on record. Third-Party Administration (TPA) Services are the primary driver. The others are entity-Owned Pharmacy Management, specialty Care Referral Services and program Integrity and Compliance Services.

Who are NuvemRx's main competitors?

Direct peers on record are Verity Solutions (McKesson), SunRx and CaptureRx. Broad incumbents are R1 RCM, RxBenefits, Omnicell, ConnectiveRx and CoverMyMeds (McKesson). Others are Apexus and Surescripts.

Does NuvemRx have an API?

No public API is recorded for NuvemRx.

What industry is NuvemRx in?

NuvemRx's product category is 340B Pharmacy Management Services. Its primary akta.pro industry code is HLACAKAC, Pharmacy Information Systems (PIS) & Dispensing Workflow, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 524292 and its SIC code is 6324.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0NuvemRx: Interview With CEO Scott Seidelmann About Technology-Enabled 340B Pharmacy ServicesNuvemRx CEO Scott Seidelmann discussed the company's technology-enabled pharmacy services, including 340B referral capture and entity-owned pharmacy management. The company has processed over 1.5 billion claims and generated more than $2.6 billion in cumulative net 340B savings across 800+ covered entities. It plans to expand adoption and deepen analytics capabilities.Business Wire BlogNuvemRx Launches Mission Control, a Strategic Intelligence Operation to Help Safety-Net Providers Get Ahead of 340B ComplexityNuvemRx launched Mission Control, a strategic intelligence operation for safety-net providers, leveraging data from 800+ covered entities. The operation draws on 1.5B+ claims and $2.6B in cumulative net 340B savings to deliver actionable guidance amid IRA-driven regulatory changes. A physical command center in Texas is planned.Healthcare IT TodayNuvemRx Acquires par8o from R1 RCM, Strengthening its Specialty Care Coordination and 340B Referral Capture CapabilitiesNuvemRx announced the acquisition of par8o, a 340B referral capture business, from R1 RCM, expanding its pharmacy solutions and referral capture capabilities for community health providers. The combined entity will support more than 800 covered entities nationwide and serve over 70 million cumulative patients through an integrated suite of third-party administration, pharmacy management, and referral services. The acquisition is designed to help safety-net organizations reduce referral leakage and automate up to 85 percent of the referral and eligibility process within the 340B program.Built In BostonNuvemRx Acquires par8o to Expand 340B Referral CapabilitiesNuvemRx, a pharmacy solutions provider, has acquired par8o, a health technology company focused on 340B referral capture, from R1 RCM. Following the acquisition, NuvemRx will support more than 800 covered entities across the United States and can automate up to 85 percent of the referral and eligibility process using AI-powered decision support. The deal is aimed at helping safety-net organizations reduce referral leakage and improve prescription-related savings while reducing administrative burden for providers.Business Wire BlogNuvemRx Acquires par8o from R1 RCM, Strengthening its Specialty Care Coordination and 340B Referral Capture CapabilitiesNuvemRx, a tech-enabled pharmacy solutions company for community health providers, has acquired the 340B referral capture business par8o from R1 RCM. The acquisition adds AI-powered referral technology and real-time referral visibility to NuvemRx's suite of services, enabling the company to support more than 800 covered entities and over 70 million cumulative patients. par8o's technology was acquired by R1 RCM as part of the Cloudmed transaction in 2022, and par8o's COO will join NuvemRx's leadership team following the deal.YahooNuvemRx Acquires par8o from R1 RCM, Strengthening its Specialty Care Coordination and 340B Referral Capture CapabilitiesNuvemRx, a tech-enabled pharmacy solutions company, announced the acquisition of the 340B referral capture business par8o from R1 RCM, expanding its capabilities to serve safety-net healthcare providers. The deal brings par8o's referral technology and AI-powered decision support into NuvemRx's suite of services, growing its network to over 800 covered entities serving more than 70 million cumulative patients. The combined offering integrates third-party administration, pharmacy management, and referral capture services under a single platform to address complexity in the federal 340B program.Business Wire Blog26Health Expands Partnership with NuvemRX to Open First Entity-Owned Pharmacy26Health announced plans to open its first entity-owned pharmacy in Orlando through an expanded partnership with NuvemRx, a tech-enabled pharmacy service provider. This initiative aims to improve patient access and care compliance while allowing 26Health to reinvest savings from the 340B program into additional community programs.